B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element
- 18 March 2004
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (12) , 992-1000
- https://doi.org/10.1038/sj.gt.3302255
Abstract
Retroviral gene transfer resulting in transgene expression selectively restricted to specific cell lineages would be desirable for many gene therapeutic applications. Such transcriptional targeting of retroviruses can be accomplished by employing eukaryotic control elements in self-inactivating (SIN) retroviral vectors, but use of these vectors is complicated by an accompanying reduction in viral titers. To overcome this restriction and address the influence of the post-transcriptional regulatory element of the Woodchuck hepatitis virus (WPRE) on viral titers and transgene expression, we developed SIN-vectors with and without WPRE. Using the enhancer-promoter of the Spleen Focus Forming virus (SFFV) to direct eGFP expression to multiple hematopoietic lineages, we show that WPRE significantly (>10 ) increased viral titers (>106 per ml of unconcentrated supernatant) and transgene expression in NIH3T3 cells in vitro. Gene expression in vivo was significantly lowered in lymphoid cells, but not in myeloid cells when WPRE was present. Furthermore, the use of WPRE in combination with the B-cell lineage-specific CD19 promoter significantly increased viral titers and allowed targeting of transgene expression by SIN-vectors specifically to B cells throughout their development in primary and secondary lymphoid organs.Keywords
This publication has 59 references indexed in Scilit:
- Lentivirus Vectors Incorporating the Immunoglobulin Heavy Chain Enhancer and Matrix Attachment Regions Provide Position-Independent Expression in B LymphocytesJournal of Virology, 2003
- Specific transgene expression in human and mouse CD4+cells using lentiviral vectors with regulatory sequences from theCD4 geneBlood, 2003
- RNA 3′ Readthrough of Oncoretrovirus and Lentivirus: Implications for Vector Safety and EfficacyJournal of Virology, 2002
- Enhanced Inhibition of Human Immunodeficiency Virus Type 1 Replication by Novel Lentiviral Vectors Expressing Human Immunodeficiency Virus Type 1 Envelope Antisense RNAHuman Gene Therapy, 2002
- Design of HIV Vectors for Efficient Gene Delivery into Human Hematopoietic CellsMolecular Therapy, 2002
- The Retroviruses Human Immunodeficiency Virus Type 1 and Moloney Murine Leukemia Virus Adopt Radically Different Strategies To Regulate Promoter-Proximal PolyadenylationJournal of Virology, 2001
- Lentiviral Vectors for Enhanced Gene Expression in Human Hematopoietic CellsMolecular Therapy, 2000
- Context Dependence of Different Modules for Posttranscriptional Enhancement of Gene Expression from Retroviral VectorsMolecular Therapy, 2000
- Self‐renewal of B‐1 lymphocytes is dependent on CD19European Journal of Immunology, 1996
- Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient miceNature, 1995